Unaudited Condensed Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Cash flows from operating activities:
Net loss	$ (5,138)	$ (20,388)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	2,907	2,715
Stock-based compensation expense	609	784
Inventory impairments and option contract abandonments	31	221
Deferred and other income tax benefit	(19)	(102)
Provision for doubtful accounts	(156)	(51)
Income (Loss) from Equity Method Investments	319	36
Cash distributions of income from unconsolidated entities	56	200
Changes in operating assets and liabilities:
Decrease in accounts receivable	1,424	1,166
Decrease in income tax receivable	0	3,859
Increase in inventory	(63,062)	(38,703)
Decrease in other assets	1,594	1,093
Decrease in trade accounts payable	(23,295)	(13,206)
Decrease in other liabilities	(28,366)	(24,982)
Other changes	(144)	(23)
Net cash used in operating activities	(113,878)	(87,453)
Cash flows from investing activities:
Capital expenditures	(3,200)	(1,772)
Investments in unconsolidated entities	(2,164)	(115)
Increases in restricted cash	(728)	(278)
Decreases in restricted cash	551	2,083
Net cash used in investing activities	(5,541)	(82)
Cash flows from financing activities:
Repayment of debt	(2,035)	(1,902)
Debt issuance costs	(32)	(1,136)
Settlement of unconsolidated entity debt obligation	0	(500)
Payments for other financing activities	(413)	(26)
Net cash used in financing activities	(2,480)	(3,564)
Decrease in cash and cash equivalents	(121,899)	(91,099)
Cash and cash equivalents at beginning of period	504,459	487,795
Cash and cash equivalents at end of period	$ 382,560	$ 396,696